Article

Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell Transplantation

2020-04-29

Abstract excerpt

Allogeneic hematopoietic cell transplantation (HCT) provides effective treatment for hematologic malignancies and immune disorders. Monitoring of post-transplant complications is critical, yet current diagnostic options are limited. Here, we show that cell-free DNA (cfDNA) in blood is a highly versatile analyte for monitoring of the most important complications that occur after HCT: graft-versus-host disease (GVHD...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b3acdf36-f03c-50b0-b776-657811f5dfd3
DOI: 10.1101/2020.04.25.061580

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell TransplantationDOI 10.1101/2020.04.25.061580Read

Cell-free DNA profiling informs all major complications of hematopoietic cell transplantationSemantic proximity Read

Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkersSemantic proximity Read

Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant MonitoringSemantic proximity Read

Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNASemantic proximity Read

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype.Semantic proximity Read

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and InfectionSemantic proximity Read

Nuances in the interpretation and utility of donor-derived cell-free DNA in lung transplantation following allogeneic hematopoietic stem cell transplantation - Case report.Semantic proximity Read

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.Semantic proximity Read

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.Semantic proximity Read

A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infectionSemantic proximity Read

Circulating cell-free DNA methylation patterns indicate cellular sources of allograft injury after liver transplantSemantic proximity Read

An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient GenotypingSemantic proximity Read